Testing a new PET scan for metastatic small cell lung cancer
Treatments studied
Part of Cancer, Lungs & breathing clinical trials.
This trial is testing a new type of PET scan that uses a radioactive tracer called 68Ga-PentixaFor to see if it can better detect metastatic small cell lung cancer compared to standard scans. You may be eligible if you have newly diagnosed, untreated metastatic small cell lung cancer and are about to start your first treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with small cell lung cancer that has spread and has not been treated yet.
- You are at least 18 years old and willing to use contraception for 3 months after the scan.
- You have a performance status score of 0 or 1 (able to do most daily activities).
- You have at least one measurable tumor that has spread, seen on a previous scan.
- You have a life expectancy of more than 3 months.
- You can lie still for about an hour for the scan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new PET scan tracer called [68Ga]Ga-PentixaFor to see if it can better detect breast cancer that has spread. You may benefit if you have triple negative breast cancer that has come back or spread, and you are looking for more precise imaging.
This trial tests a new type of PET scan that uses a special tracer to find lung tumors. The goal is to see if this scan can better detect cancer cells, which may help doctors plan the best treatment for you.
This study uses a special PET scan (68Ga-PFD3) to take pictures of small cell lung cancer tumors. The goal is to see if this scan can help doctors better diagnose and evaluate the cancer, which may guide treatment decisions.
This study uses a special PET/CT scan that targets a protein called c-Met to help diagnose and stage non-small cell lung cancer. It aims to see if this imaging method can better identify tumor locations and characteristics.
This trial tests a new imaging agent (68Ga-FL-031) to see if it can help find and stage tumors in people with small cell lung cancer, breast cancer, nasopharyngeal cancer, or other cancers. The goal is to improve diagnosis and treatment planning.
This early-stage trial tests a new radioactive tracer called [68Ga]Ga-R54 that helps doctors see certain advanced cancers (like breast, lung, colon, ovary, pancreas, or multiple myeloma) on PET scans. The tracer targets a specific protein (CXCR4) found on cancer cells, which may help doctors better detect and understand your cancer.
Hear when a new Small Cell Lung Carcinoma (SCLC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.